ArticleDysphagia2026
Swallowing Pathophysiology in Primary Sarcopenia: A Multimodal Assessment in Older Adults.
Article in Dysphagia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sex-specific predictive ability of SARC-F and SARC-CalF for ultrasound-based sarcopenia in older adults.BMC geriatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary sarcopenia, characterized by age-related decline in muscle mass and strength, is increasingly recognized as a contributor to oropharyngeal dysphagia in older adults. Understanding its mechanical and functional components is essential for early detection and intervention. This study aimed to investigate early oropharyngeal swallowing impairments in older adults with primary sarcopenia using a multimodal instrumental assessment and to evaluate the utility of combining different objective measures. In this cross-sectional study, swallowing safety and efficiency were assessed using the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) scale through fiberoptic endoscopic evaluation of swallowing (FEES) in 44 older individuals with primary sarcopenia. Additional assessments included tongue strength measurement, suprahyoid muscle activity using surface electromyography (sEMG), peak cough flow (PCF), and self-perceived swallowing symptoms evaluated using Eating Assessment Tool-10 (EAT-10). According to DIGEST overall score, 20.5% of participants showed no dysphagia (grade 0), while 56.8% had mild (grade 1), and 22.7% had moderate (grade 2) dysphagia. Participants with dysphagia (grades 1-2) showed decreased tongue strength, reduced sEMG amplitudes, longer swallowing durations, and decreased PCF compared to those with grade 0. Although these differences were not statistically significant, a trend toward early functional decline was noted. These findings suggest that in early-stage primary sarcopenia, swallowing safety may be preserved despite mild physiological deficits. This likely reflects the presence of a functional reserve within the swallowing mechanism. However, clinicians should not rely solely on this compensation, as subtle changes may precede clinically significant dysphagia. Early identification and monitoring remain crucial to prevent deterioration in this vulnerable population.
Indexed as
Identifiers
41413249What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.